DC Chemicals · Product datasheet
Mavacamten (MYK-461) · DC11524
Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.
| Parameter | Value |
|---|---|
| Chemical Name | Mavacamten |
| CAS No. | 1642288-47-8 |
| Synonyms | Mavacamten; QX45B99R3J; (S)-3-isopropyl-6-((1-phenylethyl)amino)pyrimidine-2,4(1H,3H)-dione; Mavacamten [INN]; Mavacamten [WHO-DD]; MYK461; GTPL11265; s8861; SAR439152; DB14921; SB19779; (S)-3-Isopropyl-6-((1-phenylethyl)amino) pyrimidine-2,4(1H,3H)-dione; (S)-3-Isopropyl-6-((1-phenylethyl)amino)pyrimidine-2, 4(1H,3H)-dione; (S)-3-Isopropyl-6 |
| Formula | C15N3O2H19 |
| M.Wt | 273.3303 |
| SMILES | O=C1N([H])C(=C([H])C(N1C([H])(C([H])([H])[H])C([H])([H])[H])=O)N([H])[C@@]([H])(C([H])([H])[H])C1C([H])=C([H])C([H])=C([H])C=1[H] |
| Purity | 98% |
| Storage | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Biological activity summary
Mavacamten (MYK-461) is a cardiac myosin inhibitor used to study sarcomere contractility and hypertrophic cardiomyopathy.
View referenced In Vitro and In Vivo results on the product pageReferences
Available packs
- 100 mg · US$550
- 250 mg · US$900
- 1 g · US$1,800
- 10 mM * 1 mL in DMSO · US$220
